Close Close
Popular Financial Topics Discover relevant content from across the suite of ALM legal publications From the Industry More content from ThinkAdvisor and select sponsors Investment Advisor Issue Gallery Read digital editions of Investment Advisor Magazine Tax Facts Get clear, current, and reliable answers to pressing tax questions
Luminaries Awards
ThinkAdvisor

Life Health > Life Insurance

Across the Globe, the Regulatory Vise Tightens

X
Your article was successfully shared with the contacts you provided.

During the 2012 annual meeting of the Million Dollar Round Table, held in Anaheim, Calif., June 9-13, editors of Summit Business Media’s LifeHealthPro group—Warren Hersch of National Underwriter Life & Health, Brian Anderson of Life Insurance Selling and Daniel Williams of Senior Market Advisor—met with MDRT members from New Zealand, Canada, the U.S. and the U.K. to explore regulatory, practice management and product issues and trends in the four countries.

The roundtable participants included Brian Ashe, president of Brian Ashe and Associates Ltd., Lisle, Ill.; Adrian Baker, a senior partner at St. James Places, Bristol, England; Herb Braley, Jr., president and CEO of Braley Winton Financial, Toronto, Ont.; and Scott Morrison, principal of Summit Financial Group Ltd., Auckland, New Zealand.

Hersch: MDRT President Jennifer Borislow and AALU Regulatory Reform Committee Chair Larry Rybka warn that advisors’ practices are increasingly threatened by government restrictions on agent compensation, most notably in respect to commissions. What government regulations are you facing in your respective countries and how well are you dealing with them?

Ashe: In the U.S., one area of concern in the health insurance market is the imposition of the medical loss ratio [of the 2010 Dodd-Frank Act which has effectively imposed price controls on life insurance companies as well as limits on what agents can get paid. The result is that agents who sell insurance have experienced a 20% to 80% reduction in commissions.

The second big area of concern is the proposed fiduciary standard for broker-dealers. Underpinning the proposal is a belief that only advisors who operate under a fiduciary standard can act in the client’s best interest and that commissions are unethical.

Baker: In the U.K., we’re just six months away from implementing one of the largest shake-ups in financial services in the last 30 years: the Retail Distribution Review. The legislation affects not just commissions, but also renewal commissions.

On January 1, 2013, every advisor will have to satisfy new educational requirements of the U.K.’s Financial Services Authority. There has been a massive loss of agents from the industry because of the time and cost of retraining. If you’re an independent advisor after January 1, then you can only accept fee-based compensation.

One of the most significant issues stemming from the new law is renewal commissions on policies. Clients must have the opportunity to discontinue renewal commissions if they believe they’re not receiving adequate advice or service.

For agents who have been in the business a long time, this change could have a massive effect on their income. We expect that many clients will cash out policies and buy new ones so they can turn off renewal commissions, which advisors can only receive for sales concluded before 2013.

Braley: Not much has happened in Canada bearing on compensation. But I imagine that Canada will abolish commissions at some point.

Many of the major insurers in Canada are now auditing our files on a “friendly basis.” This auditing used to be limited to mutual funds and other investment products for compliance; now it’s happening with life insurance products.

Morrison: We in New Zealand are half-way between the regulatory regimes of Canada and the U.K. Since enactment of the Financial Services Act of 2008, which was fully implemented 18 months ago, all investment advisors must meet educational requirements of a revised version of the National Certificate in Financial Services—unless they satisfy recognized alternative qualifications or designations—to become an Authorised Financial Adviser.

Most advisors have taken six months away from their practices to do this. As of 18 months ago, if you weren’t an AFA, then you couldn’t sell investment-based products.

Originally, the new educational requirements were supposed to cover both insurance and investments, but the government didn’t have the systems to cope with getting everyone through the AFA program. So they scaled back the requirement to Category 1 investment products.

Insurance products fall into Category 2. We expect that within 18 months Category 2 insurance advisors will be subject to the same requirements as Category 1 investment advisors. So we’re putting all of our insurance advisors through the AFA curriculum to stay ahead of the regulations.

After the new law went into effect, about one-third of advisors in New Zealand left the business. Also, valuations of existing practices declined because prospective buyers understood they could acquire sellers’ businesses at lower prices.

This has been an issue for many older advisors who had built up commissions-based practices over many years and had hoped to sell the businesses at retirement. When they could no longer get the prices they expected without the AFA designation, many were forced to do the exams.

Ashe: The new laws in the U.K. and New Zealand impact not only up-front commissions of advisors in these countries. If your renewal commissions drop between 20% and 80%, the resale value of your practice is much reduced. For many advisors, the renewal commissions represent a significant portion of the personal wealth they’ve accumulated over 30 or 40 years. The resale value of their practices has been totally compromised with a stroke of pen.

Hersch: Producers are also expressing growing alarm over government controls on the sale of certain products. Here in the U.S., we have the recent example of FINRA’s efforts to extend its regulatory supervision to fixed indexed annuities. In India, we’ve noted the recent ban on indexed universal life products, which Ms. Borislow says has resulted in a 50% decline in the Indian contingent of MDRT’s membership within the past year. How are you adapting to increased government regulation, restrictions or bans on the sale of certain life insurance products in your countries?

Ashe: In the U.S, we’re seeing greater regulation of products having anything to do with securities. Question is why were fixed indexed annuities put into the same classifica-

tion as securities, since the product’s principal is guaranteed by the life insurance company.

FINRA’s attempts to regulate the products resulted in a lot of confusion for broker-dealers. Some B-Ds prohibited their reps from selling fixed indexed annuities unless they were licensed in securities. One [MDRT] Top of the Table agent told me there is so much fear over this issue that his B-D will not allow him to sell a variable annuity unless the prospect has already owned a VA for five years.

Baker: Five years ago, the British government started taxing dividends inside pension schemes, which used to be tax-free. This significantly affected fund values, just at a time when pension funds were diminishing dramatically because of the financial crisis.

More recently, the government reduced the annual pension contribution limit to £50,000—about $70,000 per year. Previously, there was no maximum. The lifetime maximum for a pension fund was also cut to £1.4 million from the previous unlimited maximum.

These changes have dramatically affected pension planning in the U.K. And they have advisors asking, “What’s next?” There has been much talk that the government will eliminate the tax-favored treatment of pension contributions.

Braley: In Canada, providers of segregated funds–variable annuities–have had to substantially increase their capital reserves to maintain contract guarantees. As a result, many Canadian life insurers are exiting the business; only a handful still offer the guaranteed lifetime withdrawal benefit in the contracts. We’re writing the products like crazy now because the guarantees may not exist much longer in their current form.

Hersch: Insurance and financial service professionals also point to government tax rules that inhibit–or, if realized, could negatively impact–the sale of life insurance and the use of life insurance-funded advanced planning techniques. What tax rules governing life insurance or financial planning techniques are of concern to you? How are you adjusting your practices and product portfolios to deal with current tax rules in your own countries?

Ashe: There has been for the entire time I’ve been in the business questions about the income tax treatment of the cash value build-up of life insurance contracts. As the U.S. government has taken on greater social responsibilities, there is a greater need for tax revenue. Life insurance is the low-hanging fruit. Cash value policies, a significant element of the U.S. life insurance market, would be impacted by adverse taxation.

Also to consider are changes to laws in the last several years regarding the potential taxation of death benefits. In the business market, the employer has to give written notice, and secure the consent, to buy life insurance policies on their lives. Absent notice and consent–and there is still a lack of clarity as to what is acceptable–the death benefit of these employer owned policies would be subject to income tax.

Advisors also are challenged by a lack of clarity relative to the federal estate tax, as the current law governing estate taxes expires on December 31. Given that budgetary items will not be addressed before the November elections, it’s hard to believe that the [House and Senate] will completely reform the U.S. income, gift and estate tax laws by the December 31 deadline, since they weren’t able to do it for the ten years prior.

This continuing uncertainty presents a problem not only for producers, but also for the clients we serve. People need to know–not from year to year, but over the long-term–the level of estate tax exposure they face and whether they’ll need life insurance to cover a potential estate tax liability.

Braley: We’re always concerned about the Canadian government’s attempts to raise revenue by taxing certain products. Most recently, the government has been looking at taxing critical illness policies, specifically those with a return of premium provision. I think Canada is one of only a few countries that still offer return of premium on critical illness policies, which is a fabulous product.

The government is also looking at taxing the return of premiums to employees covered by corporate-owned policies or personally owned products. The government needs to determine whether to tax employees, based on who is paying the premium and who is receiving the benefit.

It’s wonderful that we still have policies that offer a return of premium. To be safe, some of our clients treat the premiums paid by an employer as a taxable benefit. But there isn’t anything immediately troublesome on the horizon tax-wise.

Morrison: We in New Zealand are halfway through a five-year period of a tax on the profits that life insurance companies generate from product sales. Up until three years ago, profits from term life sales were not taxable.

The current law stems from 1983, when the industry shifted from selling largely whole life products to term insurance because of a tax then imposed on profits from whole life sales. Today in New Zealand, 99% of all life insurance policies are term products. We have, unfortunately, only one whole life product to sell.

Three years ago, the government imposed a similar tax on profits from sales of term insurance. To compensate, the insurers have progressively increased the premiums they charge for the products. Unfortunately for advisors and their clients, the result has been a lowering of coverage because many policyholders can no longer afford the increased premiums.


NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.